Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.
about
The platelet activating factor (PAF) signaling cascade in systemic inflammatory responsesBlock of the background K(+) channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factorPalliation of bone cancer pain by antagonists of platelet-activating factor receptorsAttenuation of antigen-induced airway hyperresponsiveness in CGRP-deficient mice.Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cellsPlatelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitisPAF acetylhydrolase gene polymorphisms and asthma severity.Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesisPAF produced by human breast cancer cells promotes migration and proliferation of tumor cells and neo-angiogenesis.A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma.Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation-mediated effects.Lipopolysaccharide Cross-Tolerance Delays Platelet-Activating Factor-Induced Sudden Death in Swiss Albino Mice: Involvement of Cyclooxygenase in Cross-ToleranceImpaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.G-protein-coupled receptors and melanomaDifferential expression of platelet-activating factor acetylhydrolase in lung macrophages.Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.Platelet-activating factor: a previously unrecognized mediator of fever.Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor.Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury.Emerging roles of PAR-1 and PAFR in melanoma metastasis.Nuclear localization of platelet-activating factor receptor controls retinal neovascularization.Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway.Intratracheally administered pathogen-associated molecular patterns affect antibody responses of poultry.Components of a platelet-activating factor-signaling loop are assembled in the ovine endometrium late in the estrous cycle.Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants.Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.Gastrin stimulates the growth of gastric pit with less-differentiated features.Endotoxins stimulate neutrophil adhesion followed by synthesis and release of platelet-activating factor in microparticles.Disruption of ET-1 gene enhances pulmonary responses to methacholine via functional mechanism in knockout mice.Calcitonin gene-related peptide mediates acid-induced lung injury in mice.Effect of platelet-activating factor receptor expression on CHO cell motility.
P2860
Q27693180-3F147AD0-DFFF-44F2-872D-99145D55C6E6Q28217133-7EAAA142-119C-48D1-8964-D762D001F513Q28540983-8C6D7E0E-C6F1-46C5-AED6-DF5D77BF78A4Q33184839-93C1F1CB-B5E4-494B-80AF-38CF4E087F7BQ33637787-83834D64-3AEE-4A70-9F1F-B16019253DB1Q33728475-2A0FD628-F981-489A-8DA2-BDE2D3ED7F52Q34355213-260C8576-A0D5-4AC0-9134-7F8CD1FE62D3Q35795383-1D77E952-9456-4865-81E0-FB3514EF1CDBQ35829542-E0E51FBF-62E3-4162-89C1-BAD162F0BDABQ35843487-ABDAED4F-2F2F-4450-AEC7-641F6A1942EEQ35915423-E432FCFF-4F1B-4706-A740-1CF21E5A8146Q35932617-F184D24F-3242-4C28-9E14-86D3B6B691E4Q35985649-03F387CE-2129-4B10-8B84-492C5A005E86Q36400935-ECC99F25-3480-42E7-8FDF-DFE90B14A3B2Q37200841-78FC4BFE-6D36-4771-8CF5-14C35BEDC9A1Q37475022-50A0DA60-B643-4CFA-931C-AB090D9A7AC7Q38660494-7E6358E2-B043-4548-B4DD-341AEBCA1AEFQ39972669-ECEBAC78-CB87-4BF7-97D4-A52B25FFB626Q40548191-D872D065-E9A7-4F0B-A2AF-2F2CD689D866Q41091749-B8CC525A-638B-4B6F-87BD-08B16DD251A7Q41298937-FF5BD72C-600A-4DC3-AF81-A950FD256EDAQ41298964-1C7E686C-2A97-4401-B74D-4A91DE2A27B1Q41904115-D40D5550-A6EE-442E-9519-7A7542D79847Q42425245-8BDFF49B-2D53-489C-B4C6-466CC2419A88Q42450377-F5DE3A7C-AB97-4CC7-BD20-26696B648869Q43854264-C27B4292-4074-459C-B3F4-AAAF407054B7Q44773304-D4905461-4CF6-4F2C-94D1-F74F7719667BQ44991325-F70878B9-123A-4E33-81A2-C0E7711AA6A0Q46793657-182AC43F-86BC-4F15-948B-CFD21AB04425Q46818318-21861215-32FD-4B98-909D-CBF3D791A734Q50516381-431988AF-1323-4452-A1F4-F8BAD18E7D3BQ51667315-53041CF4-9F40-40BF-AB04-8F29B4B51EC6Q52537360-F8E5B0CB-2A86-436A-87BC-4EAA3BBFAD46Q52583271-7D51723A-0787-414A-80A4-FE4F3BFC7EE6Q53736678-55AD7BED-6D3E-4993-82CB-E046D590EF83
P2860
Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Bronchial hyperreactivity, inc ...... et-activating factor receptor.
@ast
Bronchial hyperreactivity, inc ...... et-activating factor receptor.
@en
type
label
Bronchial hyperreactivity, inc ...... et-activating factor receptor.
@ast
Bronchial hyperreactivity, inc ...... et-activating factor receptor.
@en
prefLabel
Bronchial hyperreactivity, inc ...... et-activating factor receptor.
@ast
Bronchial hyperreactivity, inc ...... et-activating factor receptor.
@en
P2093
P2860
P356
P1433
P1476
Bronchial hyperreactivity, inc ...... let-activating factor receptor
@en
P2093
P2860
P304
P356
10.1093/EMBOJ/16.1.133
P407
P577
1997-01-01T00:00:00Z